Skip to main content
Pharmanutra logo

Pharmanutra — Investor Relations & Filings

Ticker · PHN ISIN · IT0005274094 LEI · 815600F8217BC7733697 XMIL Manufacturing
Open in API
Filings indexed 601 across all filing types
Latest filing 2024-03-26 Remuneration Information
Country IT Italy
Listing XMIL PHN

About Pharmanutra

http://www.pharmanutra.it

PharmaNutra is a company operating in the pharmaceutical and nutraceutical sectors, focused on the development and distribution of nutritional supplements and medical devices. Grounded in scientific research, the company creates innovative solutions for health and wellness. Its core activities center on addressing nutritional deficiencies, particularly iron, through proprietary functional ingredients and technologies. The product portfolio also extends to supporting muscle and joint health, sports nutrition, and applications across various therapeutic areas, including gynecology, orthopedics, hematology, and gastroenterology. The company emphasizes the development of effective and safe products supported by clinical evidence.

Recent filings

Filing Released Lang Actions
Report on the remuneration policy and the remuneration paid
Remuneration Information Classification · 1% confidence The document is explicitly titled "REPORT ON THE REMUNERATION POLICY AND THE REMUNERATION PAID" and repeatedly refers to itself as the "Remuneration Report." It details compliance with Italian regulations (art. 123-ter of Legislative Decree 58/1998 and Consob Regulation 11971/1999) regarding the remuneration of directors and statutory auditors. This content directly corresponds to the definition of a report detailing executive compensation, which maps to the 'Remuneration Information' category. This is the report itself, not an announcement of a report (RPA/RNS), given its substantial length (over 100,000 characters) and detailed content structure (Section I and Section II). The specific code for Remuneration Information is DEF 14A, which is used for proxy statements detailing compensation.
2024-03-26 English
Relazione sulla Politica di remunerazione e sui compensi corrisposti
Remuneration Information Classification · 1% confidence The document title is "RELAZIONE SULLA POLITICA DI REMUNERAZIONE E SUI COMPENSI CORRISPOSTI" (Report on Remuneration Policy and Compensation Paid). It explicitly references Italian regulations like art. 123-ter of D.Lgs. 58/1998 and Consob regulations, which govern corporate governance and disclosure in Italy. The content details the structure, adoption, and voting procedures for the remuneration policy and paid compensation for directors and statutory auditors. This directly corresponds to the definition of a Remuneration Information document, which aligns with the US SEC filing type DEF 14A (Proxy Statement/Information Statement detailing executive compensation), although the specific Italian document type is best mapped to the closest available category related to compensation disclosure. Given the options, 'Remuneration Information' (Code: DEF 14A) is the most accurate classification for a detailed report on executive/director compensation policy and paid amounts.
2024-03-26 Italian
Avviso di deposito documentazione / Notice of publication of documents
Report Publication Announcement Classification · 1% confidence The document is titled 'AVVISO DI PUBBLICAZIONE DI DOCUMENTAZIONE RELATIVA ALL'ASSEMBLEA DEGLI AZIONISTI' (Notice of publication of documentation related to the Shareholders' Meeting). It explicitly states that certain documents (like the remuneration report and a report on an agenda item) are now available to the public, referencing an upcoming Shareholders' Meeting on April 16, 2024. The document itself is very short (4448 characters) and serves only to announce the availability of other materials, rather than being the full AGM presentation or the full remuneration report itself. This perfectly matches the definition of a Report Publication Announcement (RPA), which is used when a company announces the release or publication of other reports.
2024-03-26 Italian
ANNUAL FINANCIAL STATEMENTS 2023
Annual Report Classification · 1% confidence The document is titled 'ANNUAL FINANCIAL REPORT' for the period ending 31 December 2023. It contains comprehensive financial statements, including the Consolidated Balance Sheet, Income Statement, Cash Flow Statement, and detailed explanatory notes for PharmaNutra S.p.A. It also includes the Management Report and the Independent Auditor's Report. This aligns with the definition of an Annual Report (10-K equivalent for international entities). FY 2023
2024-03-25 English
Relazione finanziaria annuale 2023
Annual Report Classification · 1% confidence The document is titled 'RELAZIONE FINANZIARIA ANNUALE' (Annual Financial Report) for the period ending December 31, 2023, for PharmaNutra S.p.A. It contains a comprehensive table of contents detailing the management report, consolidated financial statements (balance sheet, income statement, cash flow), and notes to the financial statements. This is clearly the full annual report of the company, not an announcement or a summary. FY 2023
2024-03-25 Italian
REPORT ON CORPORATE GOVERNANCE AND OWNERSHIP STRUCTURE OF PHARMANUTRA S.P.A. - FY 2023
Governance Information Classification · 1% confidence The document is explicitly titled "REPORT ON CORPORATE GOVERNANCE AND OWNERSHIP STRUCTURE OF PHARMANUTRA S.P.A." for FY 2023. It details compliance with specific Italian regulations (article 123bis of Italian Legislative Decree no. 58/1998 - TUF) regarding share capital structure, board composition, internal control systems, and remuneration. This content directly aligns with the description of a Corporate Governance Report, which is classified under the code CGR (Governance Information). It is not a general Annual Report (10-K), an Earnings Release (ER), or a Remuneration Report (DEF 14A), although it contains sections touching upon those topics as required by the governance framework.
2024-03-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.